World class compound libraries and assays rapidly identify promising drug leads

One of the most common challenges of running a high-throughput screen is identifying promising series only to have them fail when tested as purified stocks. When a drug discovery company experienced this result, they risked missing critical milestones and falling behind their competition. Learn how Peapod Bio combines innovative and orthogonal assay solutions with world-class compound libraries to offer the most streamlined, decision-driving workflows from assay development to HTS and hit-to-lead optimization.